Rapid Generation of Virus-Specific T Cells Hel... - CLL Support

CLL Support

22,366 members38,469 posts

Rapid Generation of Virus-Specific T Cells Helps Fight Off Infection in Immunocompromised Patients

AussieNeil profile image
AussieNeilAdministrator
0 Replies

The lengthy, complex, and costly process required to produce target specific T-Cells to fight cancers and viruses is a huge barrier that needs to be overcome if this technique is ever going to be more than a laboratory curiosity that benefits only a select few patients. Despite this, researchers continue to investigate how these barriers can be overcome so that this technology can be added to our arsenal in our fight against illnesses and cancer.

Here's a report of some new research aimed to reduce the time and expense to create cells that target a number of viruses which we are at increased risk of contracting:

cancernetwork.com/news/rapi...

"Rapidly generated virus-specific T cells (VSTs) were safe and effective against five infections that commonly affect immunocompromised patients after marrow or stem cell transplantation, according to a new small study. The approach could help many patients with various types of leukemia, among many other conditions."

:

:

"The researchers used direct stimulation of peripheral blood mononuclear cells (PMBCs) from allogeneic stem cell donors, and were able to generate a 13-fold expansion of the cells within 9 to 11 days, a drastic improvement over other methods. The cells were made to recognize immunogenic antigens from five viruses: Epstein-Barr virus, adenovirus, cytomegalovirus, BK virus, and human herpesvirus 6."

Neil

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...

You may also like...

New Dana Farber Research

progression of parasitic infections and also against malaria. The drug targets a protein STAT3...

** A rapid, scalable method of assessing SARS-CoV-2 cellular immunity **

PCR assays for SARS-CoV-2-specific T cell activation. The assays are rapid, internally normalized...

SARS-CoV-2 virus-trapping chewing gum

University of Pennsylvania researchers. Transform plant cells with a gene targeted to the...

An Early Look at When CAR-T Therapy Fails Patients With CLL

statistically significant (P =.01). Patients who received a stem cell transplant after the CAR-T...

Vaccines, 3rd dose, LLS results and more

and BTKi patients than in other studies. Most untreated or 1 year post treatment patients were...